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Background
Extracellular Amyloid-b (Ab) plaques and intracellular
neuro-fibrillary tangles (NFTs) of hyperphosphorylated
Tau (τ) protein are considered to be the hallmarks of
Alzheimer’s disease (AD) [1]. Ab is secreted due to the
sequential cleavage of the amyloidb precursor protein
(APP) by b- and g- secretases (b cleavage) [1], whereas
the intracellular signalling protein glycogen synthase
kinase 3 (GSK3) has been implicated to cause τ- hyper-
phosphorylation leading to the formation of NFTs [2].
It has been shown earlier that the cleavage of APP by
a- and g- secretases (a- cleavage) is enhanced by insulin
through the PI3K- Akt pathway [3]. GSK3 is a further
downstream component of this pathway which has been
shown to induce τ phosphorylation. Inhibition of GSK3
has also been shown to increase lysosomal biogenesis
leading to autophagic degradation of APP [4].
Materials and methods
For the purposes of this study, human neuroblastoma
(SH-SY5Y) cells were used. Cells expressing wtAPP,
bovine cGMP dependent protein kinase 1-alpha (PKG1a)
and murine PKG2 were generated by lentiviral transduc-
tion and were stimulated with 200µM 8-pCPT-cGMP or/
and 1µM insulin for 15 min or 2 hrs. The cells were then
lysed and the proteins analysed by Western Blotting.
Results
SH-SY5Y cells stably overexpressing APP, PKG1a and
PKG2 were used to analyze the crosstalk between the
cGMP-PKG and insulin signalling cascades that was
reported in brown adipose tissue [5]. As is known, upon
insulin stimulation, the APP overexpressing cells showed a
marked increase in the a-cleavage of APP with increased
secreted APPa levels (sAPPa). Analyzing the insulin path-
way components in the cells overexpressing PKG (1a
or 2), a significant increase in phosphorylation of GSK3
was also seen when these cells were stimulated with
cGMP, implying that PKG influences the downstream
phosphorylation events in insulin signalling. While,
PKG1a overexpressing cells also showed a marked reduc-
tion in intracellular holoAPP levels with consequent
reduction in extracellular sAPPa levels as well.
Conclusion
Our results suggest a possible crosstalk between cGMP-
PKG and insulin signalling cascades. PKG1a and PKG2
enhanced GSK3 phosphorylation upon cGMP stimula-
tion, while PKG1a affected levels of intracellular
holoAPP thus reducing extracellular sAPPa levels.
Influence of PKG on GSK3 phosphorylation renders it
as a viable and valuable target for AD therapeutics fol-
lowing a two-pronged approach; to reduce secreted Ab
levels by enhancing lysosomal biogenesis and simulta-
neous τ hyperphosphorylation reduction.
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